Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control Leading to Personalised Interventions for People with Diabetes (DIA-LINK Study)

Status: Completed
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

The DIA-LINK Study is a prospective observational study analysing longitudinal associations and mediating links between diabetes distress (DD), depressive symptoms (DS) and glycaemic outcomes in people with type 1 diabetes (T1DM). A total of 200 people with T1DM with different levels of DD and DS are to be enrolled. At baseline, all participants are assessed for DD and DS, psychological and stress-related variables, self-reported self-management, HbA1c and inflammatory markers. This is followed by a 4-week ambulatory assessment period including continuous glucose monitoring (CGM), continuous activity tracking and daily event sampling regarding sleep, stress levels, mood and diabetes-related issues; additionally, cortisol levels are assessed on four days within this period. Three months after baseline, a follow-up assessment covers DD and DS levels, stress-related variables, self-reported self-management, HbA1c and final CGM assessment. The analyses aim to establish risk factors/protective factors regarding DD and DS, their relative impact on glycaemic outcomes and potential mediation of the associations by behavioural (e.g. self-management, physical activity), physical (e.g. heart rate variability, inflammatory activity) and mental variables (subjective stress level) in T1DM.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Type 1 Diabetes

• Diabetes duration at least 1 year

• Age between 18 and 70 years

• Sufficient German language skills

• Informed consent

• Smartphone available

Locations
Other Locations
Germany
Diabetes Center Mergentheim
Bad Mergentheim
Research Institute of the Diabetes Academy Mergentheim, Diabetes Center Mergentheim
Bad Mergentheim
Time Frame
Start Date: 2018-07-01
Completion Date: 2020-06-30
Participants
Target number of participants: 208
Treatments
No DD or DS
No diabetes distress or depressive symptoms reported (CES-D \< 22, PAID \< 40)
DD without DS
Diabetes distress but no depressive symptoms reported (CES-D \< 22, PAID ≥ 40)
DS without DD
Depressive symptoms but no diabetes distress reported (CES-D ≥ 22, PAID \< 40)
DD and DS
Both diabetes distress and depressive symptoms reported (CES-D ≥ 22, PAID ≥ 40)
Related Therapeutic Areas
Sponsors
Collaborators: University of Giessen, Helmholtz Zentrum München, German Center for Diabetes Research
Leads: Norbert Hermanns

This content was sourced from clinicaltrials.gov